The American Bottling Company v. BA Sports Nutrition, LLC

CourtSuperior Court of Delaware
DecidedFebruary 11, 2021
DocketN19C-03-048 AML CCLD
StatusPublished

This text of The American Bottling Company v. BA Sports Nutrition, LLC (The American Bottling Company v. BA Sports Nutrition, LLC) is published on Counsel Stack Legal Research, covering Superior Court of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
The American Bottling Company v. BA Sports Nutrition, LLC, (Del. Ct. App. 2021).

Opinion

IN THE SUPERIOR COURT OF THE STATE OF DELAWARE

THE AMERICAN BOTTLING ) COMPANY, ) ) Plaintiff, ) C.A. No. N19C-03-048 AML CCLD ) v. ) ) BA SPORTS NUTRITION, LLC and ) THE COCA-COLA COMPANY, ) ) Defendants. )

Submitted: December 31, 2020 Decided: February 11, 2021

MEMORANDUM OPINION

Upon Plaintiff’s Motion to Compel Documents from Defendant Coca-Cola: GRANTED IN PART

Upon Defendant Coca-Cola’s Cross-Motion to Compel Documents from Plaintiff and JAB Holding Co., LLC: GRANTED IN PART

Garrett B. Moritz, Esquire, Elizabeth M. Taylor, Esquire of ROSS ARONSTAM & MORITZ LLP, Wilmington, Delaware, Robert C. Walters, Esquire, Russell H. Falconer, Esquire, and Megan Z. Hulce, Esquire, of GIBSON DUNN & CRUTCHER LLP, Dallas, Texas, Attorneys for Plaintiff The American Bottling Company.

Rolin P. Bissell, Esquire, James M. Yoch, Jr., Esquire, Michael A. Laukaitis, II, Esquire, and Kevin P. Rickert, Esquire of YOUNG CONAWAY STARGATT & TAYLOR, LLP, Wilmington, Delaware, Michael C. Holmes, Esquire, Craig E. Zieminski, Esquire, and Andrew E. Jackson, Esquire of VINSON & ELKINS LLP, Dallas, Texas, Attorneys for The Coca-Cola Company. A. Thompson Bayliss, Esquire, Daniel J. McBride, Esquire, of ABRAMS & BAYLISS LLP, Wilmington, Delaware, David H. Bernstein, Esquire, Jyotin Hamid, Esquire, Jared I. Kagan, Esquire, and Matthew J. Petrozziello, Esquire, of DEBEVOISE & PLIMPTON LLP, New York, New York, Attorneys for Defendant BA Sports Nutrition, LLC.

LEGROW, J. The plaintiff contends the Coca-Cola Company (“Coke”) tortiously interfered

with the plaintiff’s distribution agreement with BA and Sports Nutrition, LLC

(“Bodyarmor”) by requiring Bodyarmor to terminate the distribution agreement as a

condition to Coke investing in Bodyarmor. Late in the discovery process, Coke

produced an email previously redacted for privilege in which one of Coke’s

executives recommended proceeding with the investment in Bodyarmor based on

Coke’s counsel’s advice that Bodyarmor had a right to terminate the distribution

agreement. Coke then permitted its witness to testify at deposition regarding

conversations with counsel about the risk of liability associated with the distribution

agreement’s termination. The plaintiff argues the email’s production and the

executive’s testimony waived privilege as to Coke’s communications with counsel

regarding the right to terminate the distribution agreement and the risk of liability

associated with termination.

Coke does not seriously contest waiver but seeks to limit the fallout by arguing

the Court must cabin the waiver narrowly to one particular topic and only to the

advice communicated to Coke’s executives. Those limitations largely are

inconsistent with the principles of fairness underlying the “at issue” exception to the

attorney-client privilege. Coke need not, however, produce communications

exchanged exclusively between its external counsel unless those communications

reflect or recount counsel’s communications with Coke.

1 Coke also filed its own motion to compel, arguing the plaintiff waived

privilege over its own analysis of the distribution agreement by (1) arguing that the

contract’s termination was a “clear” breach, or (2) permitting the plaintiff’s witness

to testify that he consulted counsel before ultimately concluding Bodyarmor had no

termination right. This argument is unpersuasive because the plaintiff has not placed

its privileged communications at issue and does not intend to rely at trial on

counsel’s advice. The plaintiff has, however, narrowly waived privilege regarding

the origins and revisions to one due diligence document.

BACKGROUND

In 2015, Bodyarmor entered into a distribution agreement (the “Distribution

Agreement”) with the plaintiff, The American Bottling Company (“ABC”). The

Distribution Agreement granted ABC the exclusive right to distribute Bodyarmor’s

products in most of the United States for ten years.1 Three years later, however,

Bodyarmor withdrew from that agreement and granted exclusive distribution rights

to The Coca-Cola Company (“Coke”).

A. The Merger and the Coke Deal

Bodyarmor’s decision to terminate arose in the early months of 2018, after

ABC’s upstream parent company, Dr. Pepper Snapple Group, Inc. (“DPSG”)

announced its intention to acquire Keurig Green Mountain, Inc. (“Keurig”) from its

1 Second Amended Complaint (“SAC”) ¶¶ 32-33. 2 parent JAB Holding Company, LLC (“JAB”) (the “Merger”) and rename itself

Keurig Dr. Pepper Inc. (“KDP”).2 ABC alleges in its complaint that Bodyarmor and

its Chairman and CEO, Mike Repole, initially supported the Merger. Following the

Merger, however, Bodyarmor terminated the Distribution Agreement. Bodyarmor

then granted Coke the exclusive right to distribute Bodyarmor’s products in

exchange for Coke purchasing a fifteen percent stake in Bodyarmor for $300 million

(the “Coke Deal”).3 The proceeds of Coke’s $300 million investment primarily

funded a distribution to Repole and Bodyarmor’s management.4

When it terminated the Distribution Agreement, Bodyarmor took the position

that ABC breached Section 10.2 of the Distribution Agreement by failing to request

and obtain Bodyarmor’s approval of the Merger.5 Section 10.2 of the Distribution

Agreement provided that ABC could not transfer the Distribution Agreement (or its

duties under it) without Bodyarmor’s approval, which Bodyarmor could not

withhold unreasonably.6 Bodyarmor contends the Merger effected a transfer of

ABC’s rights and obligations under the Distribution Agreement. Bodyarmor

therefore purportedly could terminate the agreement for “cause” and without paying

the liquidated damages it would have been required to pay if it terminated the

2 Id. ¶¶ 47-48. 3 Id. ¶ 76. 4 Id. ¶ 105. 5 Id. ¶ 101. 6 Id. ¶ 42. 3 agreement without cause. According to ABC, the Merger did not amount to a

transfer of the Distribution Agreement and, even if it did, Bodyarmor had no

reasonable basis to withhold its approval.

In its tortious interference claim against Coke, ABC alleges (i) Coke

conditioned its investment on Bodyarmor terminating its Distribution Agreement

with ABC, and (ii) Coke did so even though it learned during due diligence that

Bodyarmor’s termination would breach the Distribution Agreement.7 ABC alleges

Coke offered Bodyarmor a premium valuation to induce it to breach the Distribution

Agreement. In support of this allegation, ABC alleges Coke (i) refused to pay any

termination fees Bodyarmor incurred for terminating the Distribution Agreement,

and (ii) insisted that Bodyarmor indemnify Coke for any damages associated with

that termination. ABC contends these indemnity provisions and Coke’s refusal to

accept any liability associated with Bodyarmor’s termination of the Distribution

Agreement were the key sticking points in negotiations surrounding the Coke Deal.

B. ABC brings its tortious interference claim

ABC initially filed claims for breach of contract and promissory estoppel

against Bodyarmor and a claim for tortious interference against Repole.8 After

conducting discovery, including third-party discovery from Coke, ABC filed an

7 Id. ¶¶ 72-73, 131. 8 The Court recently dismissed the tortious interference claim against Repole for failure to state a claim. See Am. Bottling Co. v. Repole, 2020 WL 7787043 (Del. Super. Dec. 30, 2020). 4 amended complaint asserting a claim for tortious interference against Coke. The

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Commodity Futures Trading Commission v. Weintraub
471 U.S. 343 (Supreme Court, 1985)
Zirn v. VLI Corp.
621 A.2d 773 (Supreme Court of Delaware, 1993)
Ramada Inns, Inc. v. Dow Jones & Co., Inc.
523 A.2d 968 (Superior Court of Delaware, 1986)
Citadel Holding Corp. v. Roven
603 A.2d 818 (Supreme Court of Delaware, 1992)

Cite This Page — Counsel Stack

Bluebook (online)
The American Bottling Company v. BA Sports Nutrition, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/the-american-bottling-company-v-ba-sports-nutrition-llc-delsuperct-2021.